Sight Sciences vs Tela Bio
Sight Sciences and Tela Bio are similar in size: $77.4m and $80.3m of revenue in their latest fiscal years. Tela Bio grew faster (15.8% against -3.1%). Tela Bio kept more of each dollar of sales as profit: a net margin of -48.4% against -49.7%. Sight Sciences carries less debt relative to equity (66.3% against 881.6%).
| Latest fiscal year | Sight SciencesSGHT, 2025 | Tela BioTELA, 2025 |
|---|---|---|
| Revenue | $77.4m | $80.3m |
| Revenue growth | -3.1% | 15.8% |
| Net income | −$38.4m | −$38.8m |
| Operating margin | -48.0% | -42.0% |
| Net margin | -49.7% | -48.4% |
| Return on equity | -50.7% | — |
| Free cash flow | −$29.9m | −$28.7m |
| Cash | $92.0m | $50.8m |
| Total debt | $42.4m | $55.7m |
| Debt to equity | 66.3% | 881.6% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 186 | 150 |
| Market value | $516m | $35.2m |
| Price vs our value range | — | — |
| Moat score | 35 (Weak) | 34 (Weak) |
| Insider trades, 12 months | 2 buys, 38 sales | 7 buys, 0 sales |